138 related articles for article (PubMed ID: 34874668)
21. Neurotropism and Neuropsychiatric Symptomsi in Patients with COVID-19.
Moretti P; Brufani F; Pierotti V; Pomili G; Di Buò A; Giulietti C; Masini F; Tanku V; Bachetti MC; Menculini G; Tortorella A
Psychiatr Danub; 2021 Dec; 33(Suppl 11):10-13. PubMed ID: 34862882
[TBL] [Abstract][Full Text] [Related]
22. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
23. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.
Alonso-Lana S; Marquié M; Ruiz A; Boada M
Front Aging Neurosci; 2020; 12():588872. PubMed ID: 33192483
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis.
Ma Y; Deng J; Liu Q; Du M; Liu M; Liu J
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682448
[TBL] [Abstract][Full Text] [Related]
25. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
26. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
27. Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain?
Baig AM
ACS Chem Neurosci; 2020 Oct; 11(20):3185-3187. PubMed ID: 33030333
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms.
Settanni CR; Ianiro G; Ponziani FR; Bibbò S; Segal JP; Cammarota G; Gasbarrini A
World J Gastroenterol; 2021 Nov; 27(43):7433-7445. PubMed ID: 34887641
[TBL] [Abstract][Full Text] [Related]
29. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
30. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
[TBL] [Abstract][Full Text] [Related]
31. Long-term side effects and lingering symptoms post COVID-19 recovery.
Zarei M; Bose D; Nouri-Vaskeh M; Tajiknia V; Zand R; Ghasemi M
Rev Med Virol; 2022 May; 32(3):e2289. PubMed ID: 34499784
[TBL] [Abstract][Full Text] [Related]
32. Potential neurological effects of severe COVID-19 infection.
Nuzzo D; Picone P
Neurosci Res; 2020 Sep; 158():1-5. PubMed ID: 32628969
[TBL] [Abstract][Full Text] [Related]
33. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
Heffernan DS; Evans HL; Huston JM; Claridge JA; Blake DP; May AK; Beilman GS; Barie PS; Kaplan LJ
Surg Infect (Larchmt); 2020 May; 21(4):301-308. PubMed ID: 32310715
[No Abstract] [Full Text] [Related]
34. [Consequences of the COVID-19 pandemic for people with schizophrenia, dementia and substance use disorders].
Adorjan K; Haussmann R; Rauen K; Pogarell O
Nervenarzt; 2021 Jun; 92(6):571-578. PubMed ID: 33779773
[TBL] [Abstract][Full Text] [Related]
35. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].
Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707
[TBL] [Abstract][Full Text] [Related]
36. [Post-COVID syndrome in the neurological practice].
Cherdak MA; Mkhitaryan EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):124-129. PubMed ID: 37490677
[TBL] [Abstract][Full Text] [Related]
37. Post-COVID Care Center to Address Rehabilitation Needs in COVID-19 Survivors: A Model of Care.
Ahmad M; Kim K; Indorato D; Petrenko I; Diaz K; Rotatori F; Salhany R; Lakhi N
Am J Med Qual; 2022 May-Jun 01; 37(3):266-271. PubMed ID: 34369895
[TBL] [Abstract][Full Text] [Related]
38. Rehabilitation Strategies for Cognitive and Neuropsychiatric Manifestations of COVID-19.
Rolin S; Chakales A; Verduzco-Gutierrez M
Curr Phys Med Rehabil Rep; 2022; 10(3):182-187. PubMed ID: 35602927
[TBL] [Abstract][Full Text] [Related]
39. Central Nervous System Manifestations of COVID-19: A Critical Review and Proposed Research Agenda.
Hewitt KC; Marra DE; Block C; Cysique LA; Drane DL; Haddad MM; Łojek E; McDonald CR; Reyes A; Eversole K; Bowers D
J Int Neuropsychol Soc; 2022 Mar; 28(3):311-325. PubMed ID: 33858556
[TBL] [Abstract][Full Text] [Related]
40. [Chronic fatigue syndrome against the background of the COVID-19 pandemic].
Nikitina AJ; Levin OS
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):92-98. PubMed ID: 34870921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
